Clinical Trial Update: Evaluation of Exenatide in Patients With Diabetic Neuropathy [NA]

View source ↗

Summary

A completed clinical trial evaluating exenatide in patients with type 2 diabetes mellitus and diabetic peripheral neuropathy has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: University of Michigan | Conditions: Type 2 Diabetes Mellitus, Diabetic Peripheral Neuropathy | NA | Status: COMPLETED | Results posted: 2015-05-12